American Journal of Cardiology
Volume 104, Issue 1 , Pages 14-18 , 1 July 2009

Safety of Contrast in Stress Echocardiography in Stable Patients and in Patients With Suspected Acute Coronary Syndrome but Negative 12-Hour Troponin

Received 19 December 2008 ,Revised 20 February 2009 ,Accepted 20 February 2009.

References 

  1. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358–367
  2. Thanigaraj S, Nease RF, Schechtman KB, Wade RL, Loslo S, Pérez JE. Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing. Am J Cardiol. 2001;87:1430–1432
  3. Hoffmann R, Marwick TH, Poldermans D, Lethen H, Ciani R, van der Meer P, et al. Refinements in stress echocardiographic techniques improves interinstitutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J. 2002;23:821–829
  4. Yong Y, Wu D, Fernandes V, Kopelen HA, Shimoni S, Nagueh SF, et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patient in the intensive care unit. Am J Cardiol. 2002;89:711–718
  5. Ikonomidis I, Holmes E, Narbuvold H, Bolstad B, Muan B, Nihoyannopoulos P. Left ventricular wall motion assessment and endocardial border delineation after intravenous injection of Infoson™ during dobutamine stress echocardiography. Coron Artery Dis. 1998;9:567–576
  6. Rainbird AJ, Mulvagh SL, Oh JK, McCully RB, Klarich KW, Shub C, et al. Contrast dobutamine stress echocardiography clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr. 2001;14:375–378
  7. Varga A, Garcia MA, Picano E. Safety of stress echocardiography (from the International Stress Echo Complication Registry). Am J Cardiol. 2006;98:541–543
  8. Mathias W, Arruda A, Santos FC, Arruda AL, Mattos E, Osório A, et al. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4033 consecutive studies. J Am Soc Echocardiogr. 1999;12:785–791
  9. Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol. 1997;29:1234–1240
  10. Timperley J, Mitchell AR, Thibault H, Mirza IH, Becher H. Safety of contrast dobutamine stress echocardiography: a single center experience. J Am Soc Echocardiogr. 2005;18:163–167
  11. Tsutsui JM, Elhendy A, Xie F, O'Leary EL, McGrain AC, Porter TR. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol. 2005;45:1235–1242
  12. Aggeli C, Giannopoulos G, Roussakis G, Christoforatou E, Marinos G, Toli C, et al. Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for detection of ischemia in 5250 studies. Heart. 2008;94:1571–1577
  13. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539–542
  14. McCully RB, Roger VL, Mahoney DW, Karon BL, Oh JK, Miller FA, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol. 1998;31:144–149
  15. Gabriel RS, Smyth YM, Menon V, Klein AL, Grimm RA, Thomas JD, et al. Safety of ultrasound contrast agents in stress echocardiography. Am J Cardiol. 2008;102:1269–1272
  16. Shaikh K, Chang SM, Peterson L, Rosendahl-Garcia K, Quinones MA, Nagueh SF, et al. Safety of contrast administration for endocardial enhancement during stress echocardiography compared with noncontrast stress. Am J Cardiol. 2008;102:1444–1450
  17. Weidmann B, Lepique CU, Jansen W, Stoiber WU, Tauchert MO. Myocardial infarction as a complication of dobutamine stress echocardiography. J Am Soc Echocardiogr. 1997;10:768–771
  18. Vancraeynest D, Kefer J, Hanet C, Fillee C, Beauloye C, Pasquet A, et al. Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans. Eur Heart J. 2007;28:1236–1241
  19. Fisher NG, Christiansen JP, Klibanov A, Taylor RP, Kaul S, Lindner JR. Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol. 2002;40:811–819
  20. Nucifora G, Marsan NA, Siebelink HM, van Werkhoven JM, Schuijf JD, Schalij MJ, et al. The safety of contrast-enhanced echocardiography within 24 hours after myocardial infarction. Eur J Echocardiogr. 2008;9:816–818
  21. Plana JC, Mikati IA, Dokainish H, Lakkis N, Abukhalil J, Davis R, et al. A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease: the OPTIMIZE trial. J Am Coll Cardiol Img. 2008;1:145–152
  22. Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D, et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol. 2009;53:32–38

PII: S0002-9149(09)00660-2

doi: 10.1016/j.amjcard.2009.02.041

American Journal of Cardiology
Volume 104, Issue 1 , Pages 14-18 , 1 July 2009

Article Tools